1 |
赵亚军, 孙兴卫. 再生障碍性贫血患者T淋巴细胞亚群表达特点 [J]. 热带医学杂志, 2019, 19(2): 204-206.
|
2 |
及月茹, 李国辉, 刘强, 等. 抗人胸腺细胞免疫球蛋白/抗淋巴细胞免疫球蛋白联合环孢素A与异基因造血干细胞移植治疗再生障碍性贫血的疗效比较 [J]. 国际输血及血液学杂志, 2018, 41(6): 466-472.
|
3 |
Deng XZ, Du M, Peng J, et al. Associations between the HLA-A/B/DRB1 polymorphisms and aplastic anemia: evidence from 17 case-control studies [J]. Hematology, 2017, 23(4): 1-9.
|
4 |
付蓉. 再生障碍性贫血诊断与治疗中国专家共识(2017年版) [J]. 中华血液学杂志, 2017.
|
5 |
曾立洁, 刘春燕, 丁少雪, 等. 重型再生障碍性贫血患者SLAMF6表达状态的初步研究 [J]. 中华血液学杂志, 2018, 39(11): 927-931.
|
6 |
Ohta MA., Nagai M, Nishina, et al. Incidence of aplastic anemia in Japan: analysis of data from a nationwide registration system [J]. Int J Epidemiol, 2015, 44(suppl 1): i178-i178.
|
7 |
Gu C, Zhu X, Qiao X, et al. Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study [J]. Hematology, 2019, 24(1): 282-289.
|
8 |
孙莹莹, 邵宗鸿. 雷帕霉素在再生障碍性贫血中免疫抑制机制的研究现状 [J]. 国际输血及血液学杂志, 2018, 41(3): 199-203.
|
9 |
Jain R, Trehan A, Bansal D, et al. Aplastic anemia in children: How good is immunosuppressive therapy? [J]. Pediatr Hematol Oncol, 2019, 36(11): 1-11.
|
10 |
Yigit B, Halibozek PJ, Chen SS, et al. A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells [J]. Oncotarget, 2016, 7(18): 26346-26360.
|
11 |
Rehman S, Saba N, Naz M, et al. Single-nucleotide polymorphisms of FAS and FASL genes and risk of idiopathic aplastic anemia [J]. Immunol Invest, 2018, 47(5): 484-491.
|
12 |
张梦雪, 王小钦. 重型获得性再生障碍性贫血造血干细胞移植与免疫抑制疗法的比较与选择 [J]. 临床内科杂志, 2018, 35(9): 643-645.
|
13 |
Sun Q, Wu B, Zhu Z, et al. Allogeneic hematopoietic stem cell transplant for severe aplastic anemia: current state and future directions [J]. Curr Stem Cell Res Ther, 2018, 13(5): 350-355.
|
14 |
Risitano AM. Immune insights into AA [J]. Blood, 2017, 129(21): 2824-2826.
|
15 |
王志敏, 潘学霞, 李尊昌, 等. 抗CD137L单抗对再生障碍性贫血T细胞亚群及细胞因子诱生水平的影响及意义 [J/OL]. 临床检验杂志(电子版), 2017, 6(4): 660-662.
|
16 |
Feng X, Lin Z, Sun W, et al. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure [J]. Haematologica, 2017, 102(10): 1691-1703.
|
17 |
Guan J, Sun Y, Fu R, et al. A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy [J]. Medicine, 2019, 98(3): e14149.
|
18 |
曹玉能, 周芳, 宋宁霞, 等. 脐带间充质干细胞对再生障碍性贫血患者Treg细胞的调节影响 [J]. 中华医学杂志, 2017, 97(34): 2678-2681.
|
19 |
Van Wassenhove LD, Mochly-Rosen D, Weinberg KI. Aldehyde dehydrogenase 2 in aplastic anemia, fanconi anemia and hematopoietic stem cells [J]. Mol Genet Metab, 2016, 119(1-2): 28-36.
|
20 |
Huang J, Ge M, Lu S, et al. Impaired autophagy in adult bone marrow CD34+cells of patients with aplastic anemia: possible pathogenic significance [J]. PloS One, 2016, 11(3): e0149586.
|